Heartbeam, Inc. - Common Stock (NQ:BEAT)

HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients

Today 8:31 EDT

3 Stocks BEAT, MOBX, PRSO Now: FDA Breakthrough, Rare Earths and Military Drones Drive Catalysts

Performance

52-Week Range 89.4% below 52-week high

0.4250

0.3552W Low 4.0052W High

1 Week 19.6% below 1-week high

0.381W Low 0.531W High

Heartbeam, Inc. - Common Stock (BEAT) traded between $0.35 and $4.00 over the past 52 weeks and last traded at $0.42, 89.4% below its 52-week high. Over the past week it ranged between $0.38 and $0.53.

Past 12 Months

-13.0%

+4.7%

-35.6%

-52.0%

-82.5%

-76.3%

1W -$0.06

1M +$0.02

3M -$0.24

6M -$0.46

YTD -$2.01

1Y -$1.36

BEAT was -76.3% over the past year, -52.0% over six months, -82.5% year to date, -13.0% in the last week.

12 Months vs Market

BEAT

-76.3%

DIA

+12.4%

SPY

+16.2%

QQQ

+21.0%

IWM

+10.3%

Over the past 12 months BEAT returned -76.3% versus DIA (Dow) +12.4%, SPY (S&P 500) +16.2%, QQQ (Nasdaq 100) +21.0% and IWM (Russell 2000) +10.3%.

Volume & Liquidity 0.14× 3-mo avg

Today 981,621 3-mo avg 7.1M

1.8M

19.3M

7.1M

4.2M

YTD

3.1M

5.6M

BEAT most recently traded 981,621 shares against a 3-month average daily volume of 7.1M.

More News

These stocks have an unusual volume in today's session ↗

October 06, 2026

Via Chartmill

Which stocks are most active on Monday? ↗

October 05, 2026

Via Chartmill

October 06, 2026

Via AB Newswire

Monday's session: top gainers and losers ↗

October 05, 2026

Via Chartmill

Keep an eye on the top gainers and losers in Monday's session. ↗

October 05, 2026

Via Chartmill

Monday's session: gap up and gap down stocks ↗

October 05, 2026

Via Chartmill

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Receives FDA Breakthrough Device Designation for At-Home Heart Attack Assessment

October 05, 2026

HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment

October 05, 2026

HeartBeam, Inc. Letter to Shareholders

September 21, 2026

MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Advances Heart Attack Detection Program, Extends Cash Runway Into 2027

August 14, 2026

HeartBeam Reports Q2 2026 Results: Full Earnings Call Transcript ↗

August 13, 2026

Via Benzinga

HeartBeam Reports Second Quarter 2026 Results

August 13, 2026

MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Sets Aug. 13 Call To Review Q2 Results and Strategy

July 30, 2026

HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time

July 30, 2026

AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Patent Expands Cardiac Monitoring Platform With Heart Failure and Structural Heart Disease Capabilities

Thursday's after hours session: top gainers and losers ↗

July 16, 2026

Via Chartmill

July 14, 2026

HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device

July 14, 2026

HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule

July 01, 2026

HeartBeam Inc. (NASDAQ: BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital

June 30, 2026

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study

June 30, 2026

MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy

June 25, 2026

HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition

June 24, 2026

HeartBeam Inc. (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection

June 22, 2026